FDA approves first natalizumab biosimilar for MS treatment
Multiple sclerosis (MS) is a chronic disease affecting the central nervous system, which results in symptoms ranging from muscle weakness to vision loss and paralysis. It generally strikes in early adulthood, and is more common...
Read More